Strategic Development of an Immunotoxin for the Treatment of Glioblastoma and Other Tumours Expressing the Calcitonin Receptor
New strategies aimed at treatment of glioblastoma are frequently proposed to overcome poor prognosis. Recently, research has focused on glioma stem cells (GSCs), some quiescent, which drive expansion of glioblastoma and provide the complexity and heterogeneity of the tumour hierarchy. Targeting quie...
Main Authors: | Pragya Gupta, David L. Hare, Peter J. Wookey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2347 |
Similar Items
-
Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas
by: Anna Ostrovskaya, et al.
Published: (2019-02-01) -
Calcitonin receptor expression in medullary thyroid carcinoma
by: Virginia Cappagli, et al.
Published: (2017-09-01) -
Calcitonin-Induced Effects on Amniotic Fluid-Derived Mesenchymal Stem Cells
by: Caterina Morabito, et al.
Published: (2015-05-01) -
Mice Lacking the Calcitonin Receptor Do Not Display Improved Bone Healing
by: Jessika Appelt, et al.
Published: (2021-09-01) -
Development of High Affinity Calcitonin Analog Fragments Targeting Extracellular Domains of Calcitonin Family Receptors
by: Sangmin Lee
Published: (2021-09-01)